Company intelligence / Profile preview

EmergoPharm

Warszawa, Mazowieckie, Poland

Ownership: Private
Employees: ~9
Development stage: Other

Overview

EmergoPharm operates as a supplier and developer in medical devices, dietary supplements, and cosmetics, with programs in commercial distribution and partnerships for specific products such as the antiviral Nozitix spray on the Bulgarian and Romanian markets.

Therapeutic areas: OtherInfectious Diseases
Modalities: Small moleculeDeviceCosmetic formulation
Industry: Therapeutic Medical Devices

Partnerships

Vedra International (distribution partner for Nozitix in Bulgaria and Romania)

Beyond the preview

Go deeper on EmergoPharm.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on EmergoPharm.

Explore the full profile